i-spero® brings together decades of clinical research and proven artificial intelligence to deliver digital tools that improve recovery rates for patients whilst reducing the overall cost of treatment.
New article on predicting antidepressant treatment response was published in November issue of European Neuropsychopharmacology
We are pleased to announce that P1vital Products Ltd was awarded Innovate UK Grant.
On the evening of Thursday 24th May the inaugural Thames Valley Tech Awards 2018 were held at the Royal Berkshire Conference Centre, Madejski Stadium in Reading, UK. Having been shortlisted as a Science & Technology finalist, P1vital Products Limited was proud to be an award recipient!
The Pharmaceutical Journal examines personalised treatment to depression including P1vital® PReDicT Test which is being used in PReDicT clinical study across 5 European countries.